American pharmaceutical giant Eli Lilly is investing 3 billion dollars (roughly 2.6 billion euros) to build a new factory in ...
If it wasn’t already clear, Virginia is doubling down on life sciences. State officials have teamed up with a trio of top ...
UD chemical engineer wins the AIChE Langer Prize for efforts to harness biology to manage plastic waste sustainably ...
US pharmaceutical company Eli Lilly said on Monday it will invest around €2.7 billion in a new production facility near the ...
Along with the company’s investment plans in Puerto Rico, Lilly also announced plans to build a $5 billon manufacturing plant ...
This year’s Asia’s Power Businesswomen list highlights 20 accomplished leaders who are at the forefront of the region’s ...
Opinion
13hon MSNOpinion
DR. MAKARY, DR OZ: People talk about lowering healthcare costs, but the Trump administration is doing it
FDA announces major reforms to streamline biosimilar approvals, potentially saving Americans billions on prescription drug costs by removing extra clinical trial requirements.
ET BrandEquity on MSN
Amazon’s layoffs show how AI is coming for India
Amazon's global job cuts warn India about AI's impact on white-collar jobs. Generative AI threatens roles in finance, ...
The European Union (EU) and France have committed a €10.2 million investment to strengthen Nigeria’s pharmaceutical manufacturing ...
The Indianapolis-based pharmaceutical company said the new site will manufacture its weight-loss pill, orforglipron, and other oral medicines.
(Reuters) -Eli Lilly said on Monday it plans to build a new $3 billion manufacturing plant in the Netherlands to expand the production capacity for its keenly watched weight-loss pill, orforglipron, ...
Phlow Corp., a leading American advanced pharmaceutical contract development and manufacturing organization (CDMO), congratulates Governor Glenn Youngkin, the Virginia Innovation Partnership ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results